Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.56B |
| 2 |
Amazon
AMZN
|
+$1.34B |
| 3 |
Eli Lilly
LLY
|
+$1.26B |
| 4 |
NVIDIA
NVDA
|
+$1.08B |
| 5 |
Chevron
CVX
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$964M |
| 2 |
ANSS
Ansys
ANSS
|
+$924M |
| 3 |
Johnson & Johnson
JNJ
|
+$753M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$418M |
| 5 |
American Express
AXP
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.52% |
| 2 | Financials | 13.57% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Communication Services | 9.71% |
| 5 | Healthcare | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
TORM
TRMD
$3.01B
| $1.85M | ﹤0.01% |
89,865
+6,732
| +8% | +$135K |
|
3202
Biote Corp
BTMD
$42.7M
| $1.84M | ﹤0.01% |
612,240
-4,457
| -0.7% | -$15.9K |
|
3203
FitLife Brands
FTLF
$105M
| $1.82M | ﹤0.01% |
91,698
+952
| +1% | +$15.3K |
|
3204
Smith Douglas Homes
SDHC
$119M
| $1.82M | ﹤0.01% |
103,016
+1,120
| +1% | +$21.9K |
|
3205
Protalix BioTherapeutics
PLX
$190M
| $1.82M | ﹤0.01% |
819,777
-6,556
| -0.8% | -$10.7K |
|
3206
Bally's
BALY
$660M
| $1.81M | ﹤0.01% |
163,410
-1,145
| -0.7% | -$11.5K |
|
3207
Ring Energy
REI
$349M
| $1.81M | ﹤0.01% |
1,662,751
+375,116
| +29% | +$340K |
|
3208
Twin Disc
TWIN
$349M
| $1.81M | ﹤0.01% |
129,691
-194
| -0.1% | -$2.1K |
|
3209
ProFrac Holding
ACDC
$958M
| $1.81M | ﹤0.01% |
487,891
-59,928
| -11% | -$330K |
|
3210
Inhibikase Therapeutics
IKT
$378M
| $1.8M | ﹤0.01% |
1,112,574
+45,874
| +4% | +$79.5K |
|
3211
Arena Group
AREN
$56.7M
| $1.8M | ﹤0.01% |
329,117
-108,807
| -25% | -$677K |
|
3212
Empire Petroleum
EP
$111M
| $1.79M | ﹤0.01% |
396,974
-54,172
| -12% | -$261K |
|
3213
Exagen
XGN
$159M
| $1.79M | ﹤0.01% |
163,255
+16,772
| +11% | +$149K |
|
3214
ZIM Integrated Shipping Services
ZIM
$3.23B
| $1.79M | ﹤0.01% |
132,588
+13,370
| +11% | +$203K |
|
|
PTRN
3215
Pattern Group Inc
PTRN
$4.05B
| $1.79M | ﹤0.01% |
+130,542
| New | +$1.82M |
|
3216
Lifezone Metals
LZM
$341M
| $1.78M | ﹤0.01% |
324,507
-4,001
| -1% | -$18.4K |
|
3217
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $1.77M | ﹤0.01% |
45,562
-5,380
| -11% | -$175K |
|
3218
Wheels Up
UP
$187M
| $1.77M | ﹤0.01% |
47,946
+217
| +0.5% | +$7.91K |
|
3219
Neumora Therapeutics
NMRA
$321M
| $1.76M | ﹤0.01% |
968,928
+52,113
| +6% | +$84.2K |
|
3220
MediWound
MDWD
$174M
| $1.76M | ﹤0.01% |
97,833
-1,225
| -1% | -$22.6K |
|
3221
Alpha Teknova
TKNO
$396M
| $1.76M | ﹤0.01% |
284,419
-14,431
| -5% | -$67.8K |
|
3222
Zura Bio
ZURA
$540M
| $1.76M | ﹤0.01% |
405,304
-1,932
| -0.5% | -$3.47K |
|
|
GRSD
3223
Grandstand Limited Ordinary Shares
GRSD
$67.3M
| $1.76M | ﹤0.01% |
214,550
-534
| -0.2% | -$5.17K |
|
|
MSB
3224
Mesabi Trust
MSB
$305M
| $1.75M | ﹤0.01% |
59,677
+48,635
| +440% | +$1.43M |
|
|
EEX
3225
DELISTED
Emerald Holding
EEX
| $1.73M | ﹤0.01% |
340,699
-40,808
| -11% | -$206K |
|
Similar funds
Geode Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Geode Capital Management held 4,592 positions worth $1.57T, up 9.9% from $1.43T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q3 2025 filing shows 148 new, 2,907 increased, 1,130 reduced and 119 closed positions. Its largest new stake was Paramount Skydance Corp: 8,343,504 shares worth $158M. The largest sale was Hess, an estimated $964M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q3 2025 buy was Paramount Skydance Corp: 8,343,504 shares worth $158M.
- Geode Capital Management added most to Applovin in Q3 2025, an estimated $1.56B increase.
- Geode Capital Management's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $753M.
- Geode Capital Management fully exited Hess in Q3 2025, selling an estimated $964M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.57T portfolio in Q3 2025.
- Geode Capital Management opened 148 new positions and closed 119 in Q3 2025.
- Geode Capital Management's portfolio value rose 9.9% quarter-over-quarter to $1.57T.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.